InvestorsHub Logo
Followers 4
Posts 1191
Boards Moderated 0
Alias Born 10/03/2015

Re: NY1972 post# 259

Sunday, 07/10/2016 12:02:14 PM

Sunday, July 10, 2016 12:02:14 PM

Post# of 977
ABT 510 is a Thrombospondin-1 (TSP-1) mimetic drug with anti-angiogenic properties. Subcutaneous doses up to 200 mg/day, is tolerated well with concurrent TMZ and RT in patients with newly diagnosed GBM

http://meetinglibrary.asco.org/content/35049-65